Internal Medicine, Gastroenterology · Saint Louis, MO
NPI
1265458574
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4921 Parkview Pl, Div Im Gastroenterology, Ste 12b
Saint Louis, MO, 63110
Phone (314) 747-2066
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
551 services
Medicare patients, 2024
407
Average age 69
Drug cost, 2024
$2.0M
4,625 prescriptions
Company payments, 2025
$4,921
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Crippin was code 99213 (office e&m - established), 197 times for 194 patients. In total Jeffrey S Crippin billed 551 services in 22 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 197 | 194 | $61.91 | $12K |
| 99214 Office E&M - Established | Office | 128 | 122 | $80.52 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 101 | 26 | $59.16 | $5,976 |
| 99203 Office E&M - New | Office | 34 | 34 | $80.99 | $2,754 |
| 99222 Hospital E&M - Initial | Facility | 22 | 22 | $99.75 | $2,194 |
| 99204 Office E&M - New | Office | 14 | 14 | $126.83 | $1,776 |
By year: 2022 $56K for 691 services; 2023 $53K for 657 services; 2024 $40K for 551 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Crippin prescribed most often to Medicare patients was Tacrolimus, with 916 prescriptions and refills. In total Jeffrey S Crippin wrote 4,625 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 916 | 1,644 | 166 | $128K |
| Ursodiol Generic | 600 | 1,135 | 121 | $103K |
| Spironolactone Generic | 252 | 353 | 55 | $2,091 |
| Entecavir Generic | 249 | 338 | 35 | $28K |
| Furosemide Generic | 230 | 354 | 64 | $919 |
| Mycophenolate Mofetil Generic | 228 | 390 | 41 | $34K |
| Mycophenolic Acid Mycophenolate Sodium | 192 | 267 | 33 | $26K |
| Pantoprazole Sodium Generic | 166 | 268 | 38 | $1,134 |
| Azathioprine Generic | 165 | 374 | 39 | $4,583 |
| Envarsus Xr Tacrolimus | 160 | 184 | 18 | $110K |
| Prednisone Generic | 139 | 213 | 33 | $725 |
| Lactulose Generic | 113 | 147 | 31 | $5,423 |
| Ondansetron Hcl Generic | 111 | 113 | 17 | $1,002 |
| Xifaxan Rifaximin | 80 | 80 | 14 | $284K |
| Ocaliva Obeticholic Acid | 72 | 94 | Under 11 | $864K |
Brand drugs: - claims; generic drugs: 4,138 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Crippin $4,921 ($4,921 in general payments such as food, travel and fees) from 1 company. The largest payer was Bard Peripheral Vascular, Inc. with $4,921.
| Company | Payments | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. BDX | 7 | $4,921 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.